AstraZeneca.
company in Osaka, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
One to three months ago
-
Corporate stocks, including AstraZeneca and CMG, reacted to analyst ratings and U.S. Treasury buyback plans.Some support2 reports
-
Bristol-Myers Squibb and AstraZeneca announced a collaboration on advanced cancer drug development.Some support1 report
-
Barclays and AstraZeneca are noted as major listed companies amid positive market sentiment for miners and lenders.Some support1 report
-
Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.Some support1 report
Gone quiet
No new reports in 90+ days-
A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.Some support3 reports
-
GSK and AstraZeneca announce a partnership aimed at gaining access to the mainland China market.Some support1 report
-
The European Union granted approval for Enhertu, a drug co-developed by AstraZeneca and Daiichi Sankyo.Some support2 reports
-
AstraZeneca is seeking regulatory approval for new products, while analysts are tracking how these developments affect stock valuation.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around AstraZeneca this week
News at the entities that move AstraZeneca most-
FDA StructuralForbes named Elizabeth Holmes one of the richest women, while Theranos claimed FDA approval for its Herpes test.Moves AstraZeneca
-
Morgan Stanley OperationalBank of America lowered its target price on Coursera shares, while Morgan Stanley also set a price objective for the company.Moves AstraZeneca
-
Iran Shared contextLobby drives military strike against Iran in 2007.Moves AstraZeneca
-
Bristol-Myers Squibb OperationalBristol-Myers Squibb and Özlem Türeci presented late-stage oncology pipeline data and joint development activity in Mainz.Moves AstraZeneca
-
GSK OperationalThe FDA approved GSK's Jemperli drug, while Memorial Sloan Kettering Cancer Center was involved in the AZUR-1 trial.Moves AstraZeneca
-
Merck KGaA OperationalNasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.Moves AstraZeneca
Connections
The 15 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Pascal Soriot Structural
Pascal Soriot holds the role of Chief Executive Officer of AstraZeneca.
-
Morgan Stanley Operational
Morgan Stanley's analyst targets influence market perception and stock valuation of AstraZeneca.
-
Daiichi Sankyo Operational
AstraZeneca and Daiichi Sankyo are actively engaged in both co-developing drugs and competing in the HER2-mutant NSCLC treatment market.
-
Bristol-Myers Squibb Operational
The two companies are currently engaged in a collaborative partnership focused on developing advanced cancer drugs.
-
GSK Operational
GSK and AstraZeneca have formed a partnership to gain access to the mainland China market.
-
Merck KGaA Operational
The two companies actively compete against each other within the global pharmaceutical market.
-
FDA Structural
AstraZeneca seeks regulatory approval from the FDA for new products.
-
AstraZeneca Transactional
Acquired global rights to Dizal's Zegfrovy.
Show all 15 connections
-
Barclays Mentioned together
Both entities are noted as major listed companies in their respective global markets.
-
Iran Shared context
AstraZeneca's drug trials are constrained by geopolitical risks associated with Iran.
-
Alnylam Pharmaceuticals Operational
The relationship is characterized by competitive influence where clinical failures of rival drugs affect the risk profiles of both companies.
-
Citibank Mentioned together
Citibank provided a price target upgrade for AstraZeneca.
-
Ionis Pharmaceuticals Structural
Ionis Pharmaceuticals and AstraZeneca are formal partners in drug development, as evidenced by AstraZeneca's trial failure impacting the collaboration.
-
Deutsche Bank None
No evidence of a relationship between AstraZeneca and Deutsche Bank was found in the provided timeline.
-
gold Mentioned together
No direct relationship between AstraZeneca and gold was observed in the provided evidence.
History
Events by the month they beganAugust 2026
3 events- Corporate stocks, including AstraZeneca and CMG, reacted to analyst ratings and U.S. Treasury buyback plans.
- Bristol-Myers Squibb and AstraZeneca announced a collaboration on advanced cancer drug development.
- Barclays and AstraZeneca are noted as major listed companies amid positive market sentiment for miners and lenders.
July 2026
3 events- Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.
- A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.
- GSK and AstraZeneca announce a partnership aimed at gaining access to the mainland China market.